Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 15.21% vs -28.79% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 39.51% vs -24.90% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 29.70% vs 2.41% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 70.18% vs -69.68% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Mediplantex National Pharmaceutical JSC With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 15.21% vs -28.79% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -38.08% vs 45.21% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 39.51% vs -24.90% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -38.11% vs 47.83% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 29.70% vs 2.41% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -28.90% vs 87.72% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 70.18% vs -69.68% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -35.19% vs -24.08% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






